IN2013MU02631A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02631A
IN2013MU02631A IN2631MU2013A IN2013MU02631A IN 2013MU02631 A IN2013MU02631 A IN 2013MU02631A IN 2631MU2013 A IN2631MU2013 A IN 2631MU2013A IN 2013MU02631 A IN2013MU02631 A IN 2013MU02631A
Authority
IN
India
Prior art keywords
preparation
sugar alcohol
rate controlling
pharmaceutical composition
controlling polymer
Prior art date
Application number
Other languages
English (en)
Inventor
Panagiotis Ganepharm S A Barmpalexis
Agni Genepharm S A Grypioti
Jayanta Kumar Genepharm S A Mandal
Original Assignee
Genepharm India Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genepharm India Pvt Ltd filed Critical Genepharm India Pvt Ltd
Priority to PCT/IN2014/000523 priority Critical patent/WO2015022703A1/en
Priority to IN2631MU2013 priority patent/IN2013MU02631A/en
Publication of IN2013MU02631A publication Critical patent/IN2013MU02631A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2631MU2013 2013-08-12 2014-08-11 IN2013MU02631A (enrdf_load_stackoverflow)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2014/000523 WO2015022703A1 (en) 2013-08-12 2014-08-11 A stable pharmaceutical composition of fesoterodine hydrochloride
IN2631MU2013 IN2013MU02631A (enrdf_load_stackoverflow) 2013-08-12 2014-08-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2631MU2013 IN2013MU02631A (enrdf_load_stackoverflow) 2013-08-12 2014-08-11

Publications (1)

Publication Number Publication Date
IN2013MU02631A true IN2013MU02631A (enrdf_load_stackoverflow) 2015-06-19

Family

ID=52468120

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2631MU2013 IN2013MU02631A (enrdf_load_stackoverflow) 2013-08-12 2014-08-11

Country Status (2)

Country Link
IN (1) IN2013MU02631A (enrdf_load_stackoverflow)
WO (1) WO2015022703A1 (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201721437A2 (tr) * 2017-12-25 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110171274A1 (en) * 2008-07-21 2011-07-14 Actavis Group Ptc Ehf Fesoterodine Substantially Free of Dehydroxy Impurity
EP2198857A1 (en) * 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
EP2508175A1 (en) * 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
GR1007628B (el) * 2011-07-27 2012-06-29 Φαρματεν Αβεε, Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου

Also Published As

Publication number Publication date
WO2015022703A1 (en) 2015-02-19

Similar Documents

Publication Publication Date Title
EP3378859A4 (en) Benzofuran derivative, preparation method thereof and use thereof in medicine
ZA201802303B (en) Pharmaceutical composition containing anionic drug, and preparation method therefor
EP3272387A4 (en) Drug administration device, and manufacturing method for drug administration device
EP3020407A4 (en) Traditional chinese medicine composition, and preparation and application thereof
EP3020408A4 (en) Traditional chinese medicine composition, and preparation and application thereof
EP3440579A4 (en) INNOVATIVE MODEL OF DELIVERY, PROCESSING AND PAYMENT FOR SPECIALIZED MEDICINES
EP3100731A4 (en) Ligand-cytotoxicity drug conjugate, preparation method therefor, and uses thereof
SG10201507607RA (en) Process For Producing Traditional Chinese Medicine Compositions, And Compositions Obtainable By The Process
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
EP3281527A4 (en) Antimicrobial traditional chinese medicine composition, and preparation method and use thereof
MX359288B (es) Forma iv del clorhidrato de ivabradina.
EP3133071A4 (en) C-aryl indican derivative, and pharmaceutical composition thereof, preparation method therefor and uses thereof
SG11201509436TA (en) Pharmaceutical composition, preparation and uses thereof
IN2014DN06966A (enrdf_load_stackoverflow)
EP3048103A4 (en) Immune adjustment compound, use thereof and pharmaceutical composition comprising same
IN2013MU00711A (enrdf_load_stackoverflow)
EP3263155A4 (en) Drug solution administering device
HRP20181274T1 (hr) Farmaceutska mješavina za pripremu infuzijskih otopina antimikrobnih pripravaka, njezin proizvodni proces
MX2017001487A (es) Sofosbuvir en forma cristalina y proceso para su preparacion.
EP3020417A4 (en) Pharmaceutical composition for respiratory administration
WO2014107596A8 (en) Compositions and methods for polynucleotide transfection
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
EP3351286A4 (en) DEVICE FOR THE ADMINISTRATION OF A MEDICAMENT SOLUTION
IN2013MU01985A (enrdf_load_stackoverflow)
EP3159349A4 (en) Lobaplatin crystal, preparation method and pharmaceutical application